Biotech entity
clinical-trial is the sole category represented across all 2 tracked stories. Africa CDC is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.3 stories per week across a 51-day span.
Last mentioned: Aug 7, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
clinical-trial is the sole category represented across all 2 tracked stories. Africa CDC is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.3 stories per week across a 51-day span. The 8 average consequence score is above the beat benchmark of 6.4 in the same window. Source depth averages 4 original sources per story, versus 4.4 across the same-window beat baseline. Jean Kaseya appears in 2 tracked Biotech stories published from June 15, 2026 through August 4, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 201 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Jean Kaseya. Shared-story counts are live from our verified record — not editorial picks.
Leadership Visits and Latest Data Released
Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
Healthcare Workers Issue Ultimatum
In Mongbwalu, healthcare workers threatened to escalate action within 24 hours if unpaid wages were not resolved.
Uganda Declared Ebola‑Free
Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
Outbreak Declared
Eastern Congo Ebola outbreak officially declared, later linked to Bundibugyo virus.
Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Source: wfmj.com · orlandosentinel.com
The rare Bundibugyo Ebola virus has infected 782 people and killed 181 in Congo, with a record 72 new cases in one day. No approved vaccine or treatment exists for this strain, creating an urgent gap for biotech and pharma to address with rapid countermeasure development.
Jean Kaseya is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
